is oral semaglutide effective ADA 2025: Demonstrates Cardiovascular Benefits in SOUL Trial Who Prescribes Oral Semaglutide in

Note: This table is for informational purposes

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

The FDA also warns that there are no injectable products approved to lighten the skin

This ensures you receive medication at peak potency, maximizing your results on the personalized dosing plan created by PlexusDx clinicians

Compounded semaglutide and tirzepatide may be incorporated as part of the overall approach